Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Maxi-K channel modulators from Bayer

May 3, 1996

Berlex attempts to block approval of Avonex in U.S.

May 3, 1996

Pola describes dopamine reuptake inhibitors for Parkinson's disease

May 3, 1996

Astrotactin-producing gene may aid in understanding of epilepsy

May 3, 1996

Novel sertraline composition for mood disorders

May 3, 1996

Asahi discloses anxiolytic/cognition-enhancing drugs

May 3, 1996

Eisai returns sumatriptan rights to Glaxo Wellcome

May 3, 1996

Phase III data for Quadramet presented at ASCO

May 3, 1996

Zambon claims (S)-ibuprofen composition

May 3, 1996

Droxidopa studied in patients with chronic pain

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...